In this review, we outline how the dynamics of intestinal immune responses driven by IL-25 and IL-33 impact CRC development in the context of CRC subtypes, with reference to how different mouse models provide insight (sometimes imperfect) into the immune reactions in the tissues in different subtypes of CRC. Here, IL33 is linked to colorectal carcinoma.